In recent years, the explosion of science and technology has contributed to transformative changes across all aspects of life and society, including the fields of healthcare and dietary supplements. Among these advancements, Emuldrop technology is recognized as a breakthrough that may usher in a new era for enhancing the absorption and bioavailability of active ingredients within the body.
The absorption capacity of children is one of the key factors influencing their overall physical and intellectual development. Nutritional deficiencies or risks of malnutrition and stunted growth in children are often partly due to poor nutrient absorption by the body.
For example, in the case of vitamin D3, scientists have indicated that the requirement remains high across all stages of growth, from infancy through to adolescence (ages 1–18). While vitamin D3 can be supplemented via sunlight exposure or dietary intake, food-based supplementation presents several challenges. This micronutrient is easily lost during cooking processes, and its content in food is often minimal.
To effectively address the need for sufficient intake of essential vitamins and minerals in children, Emuldrop technology was developed—creating a significant impact in the global pharmaceutical industry by enhancing absorption, release, and optimizing the bioavailability of vitamin D3 in the body.
Emuldrop technology was developed by Gricar Pharmaceutical Company in Italy. With over 50 years of development, Gricar is one of the pioneering companies investing in research and development of cutting-edge pharmaceutical technologies. While conventional pharmaceutical and nutraceutical formulations often struggle with the stability and intestinal absorption of active compounds after oral administration, Emuldrop technology successfully overcomes these challenges.
Outstanding Advantages of Emuldrop Technology:
- A proprietary, patent-pending technology that represents a breakthrough in pharmaceutical dispersion systems, enhancing the stability and absorption of active ingredients by up to 13 times.
- Proven effectiveness when applied to nutrients such as vitamin D3 and vitamin K2, especially in pediatric use.
- Based on a micelle system — an advanced dispersion system that maintains the integrity and quality of active ingredients without compromising their biological properties or bioavailability.
- High potential for application across a wide range of active compounds.
- Effectively addresses the limitations of traditional forms with lower bioavailability, significantly improving the absorption of active ingredients.
- Emuldrop technology eliminates the need for preservatives commonly found in conventional products, making it particularly safe for young children.
Emuldrop has been successfully registered for intellectual property protection in Italy. Notably, it is exclusively licensed and imported by EUSTA CO.,LTD, in partnership with the Gricar manufacturing plant (Italy). Chuan Au has strategically partnered with a reputable distributor with strong market potential to bring Emuldrop-based products to the Vietnamese market.
After many years of development, Chuan Au has become a trusted brand, earning the confidence and satisfaction of customers with its motto: “For the health and future of Vietnamese people.” The company is consistently dedicated to exploring and researching unique products, exclusive technologies, as well as patented formulations and ingredients, to establish partnerships and import them for pharmaceutical companies and distributors in Vietnam.